NCT00520819View on ClinicalTrials.gov

Oslo Antioxidant Study

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

March 31, 2005

Conditions
Cardiovascular Disease
Interventions
DRUG

Antioxidant-rich food items

Trial Locations (1)

0407

Ullevål University Hospital, Oslo

All Listed Sponsors
collaborator

Ullevaal University Hospital

OTHER

lead

University of Oslo

OTHER

NCT00520819 - Oslo Antioxidant Study | Biotech Hunter | Biotech Hunter